Trials / Unknown
UnknownNCT01541449
Plaqenil Role in Prevention of Age Related Macular Degeneration
Observational Study Between People That Use Plaquenil and Those Who do Not in Prevention of AMD.
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (estimated)
- Sponsor
- Ziv Hospital · Other Government
- Sex
- All
- Age
- 20 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
The investigators think that there is a connection between the use of plaquenil and the prevention of Age related macular degeneration (AMD). The investigators believe that the use of plaquenil makes bruch's membrane thicker, thereby preventing Chroidal Neovascularization (CNV) growth.
Detailed description
the study is done by comparing to groups RA patients who take plaquenil Vs. group of patients who do not take plaquenil. after measuring the retina thickness we compare the avg. thickness of both groups.
Conditions
Timeline
- Start date
- 2012-01-01
- Completion
- 2012-04-01
- First posted
- 2012-03-01
- Last updated
- 2012-03-01
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT01541449. Inclusion in this directory is not an endorsement.